Abstract
This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have